+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
miRNA Sequencing & Assay Market by Product Type, Technology, Application, End User, Workflow, Sample Type - Global Forecast to 2030- Product Image
miRNA Sequencing & Assay Market by Product Type, Technology, Application, End User, Workflow, Sample Type - Global Forecast to 2030- Product Image
Sale

miRNA Sequencing & Assay Market by Product Type, Technology, Application, End User, Workflow, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454830
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The miRNA Sequencing & Assay Market grew from USD 380.21 million in 2024 to USD 435.69 million in 2025. It is expected to continue growing at a CAGR of 14.19%, reaching USD 843.15 million by 2030.

Decoding the Promise of miRNA Sequencing and Assay

MicroRNA sequencing and assay technologies have rapidly emerged as transformative tools that illuminate the complexities of gene regulation and cellular behavior. By capturing the expression patterns of small noncoding RNAs, these platforms deliver unprecedented granularity in biomarker discovery, disease profiling, and therapeutic targeting. Over the past decade, advances in library preparation, probe design, and detection sensitivity have shifted microRNA analysis from a niche research workflow to a cornerstone of precision medicine efforts. As demand for robust, high-throughput approaches grows, stakeholders across academia, clinical diagnostics, and drug development are recalibrating their investments to harness the power of microRNA insights. The convergence of enhanced assay kits, scalable sequencing platforms, and sophisticated bioinformatics pipelines has set the stage for an era where miRNA signatures guide personalized interventions and accelerate translational breakthroughs. This introduction frames the critical role of miRNA sequencing and assays in decoding gene networks, informing real-time clinical decisions, and driving the next frontier in life science innovation.

Emerging Shifts Rewriting the miRNA Landscape

The miRNA landscape is undergoing profound shifts driven by technological maturation, evolving applications, and an expanding ecosystem of analytical tools. Single-cell resolution has moved beyond proof of concept to integrated workflows that dissect cellular heterogeneity in tumor microenvironments and developmental biology. At the same time, artificial intelligence-powered analytics are streamlining pattern recognition in complex datasets, enabling real-time interpretation of expression profiles and accelerating candidate validation. Instrument manufacturers are offering modular platforms that support multiplexed assays, while reagent suppliers optimize chemistries for minimal input and maximal reproducibility. These innovations have fostered a democratization of miRNA sequencing, reducing barriers to entry for smaller laboratories and emerging markets. Additionally, collaborations between instrument developers and cloud-based service providers have established seamless end-to-end solutions that address both data generation and interpretation. As these shifts solidify, the boundaries between basic research, clinical diagnostics, and therapeutic monitoring are blurring, paving the way for integrated miRNA applications that span the entire spectrum of discovery to patient care.

Tariff Ripples Altering Market Currents in 2025

The introduction of new tariffs on imported sequencing instruments, reagents, and consumables in early 2025 has reverberated across the miRNA ecosystem, prompting stakeholders to reassess sourcing strategies and cost structures. Laboratories dependent on foreign-manufactured sequencing platforms have encountered escalated capital expenditures, while service providers face margin compression as reagent prices climb. In response, several organizations have intensified negotiations with domestic suppliers, explored alternative technologies with lower trade exposure, and accelerated inventory planning to buffer against further duties. The cumulative impact of these measures has been a realignment of procurement cycles, with some academic institutions delaying upgrades until tariff uncertainty stabilizes. Meanwhile, commercial assay kit developers are diversifying their manufacturing footprints to mitigate duty burdens and maintain competitive pricing. Though the long-term outcome remains contingent on policy developments, the current tariff environment underscores the importance of resilient supply chains and strategic supplier partnerships in sustaining growth and innovation in the miRNA sector.

Unveiling Market Segments Driving miRNA Innovation

A nuanced understanding of market segmentation reveals the multifaceted drivers shaping demand for miRNA sequencing and assay solutions. In the realm of product type, commercial attention is converging on expression assay kits that span microarray to qRT-PCR chemistries, alongside sequencing platforms that deliver comprehensive small RNA profiling and specialized service offerings in bioinformatics and sequencing. Technological segmentation underscores the continued relevance of microarray and qRT-PCR methods alongside accelerating adoption of next-generation sequencing for high-resolution discovery. Application-focused demand oscillates between clinical diagnostics, where miRNA signatures inform prognostic and diagnostic panels, disease research aimed at unraveling pathogenic mechanisms, and drug discovery initiatives that leverage expression patterns to identify novel targets. The end user landscape is equally diverse, with academic institutions driving foundational research, contract research organizations scaling solutions for pharma partners, and hospitals and diagnostic laboratories integrating assays into clinical workflows, while pharmaceutical and biotech companies push for companion diagnostics. Workflow segmentation highlights the interplay between consumables-kits, reagents, and labware-and services encompassing data analysis and sequencing, each optimized for rapid turnaround and reproducible performance. Finally, sample type segmentation underscores the critical role of blood, serum or plasma, and tissue specimens in capturing robust, clinically relevant miRNA profiles. Together, these intersecting segments define a dynamic market where tailored solutions meet the evolving needs of research and clinical end users.

Regional Dynamics Shaping miRNA Adoption Worldwide

Regional dynamics are reshaping the global footprint of miRNA sequencing and assay adoption. In the Americas, robust funding pipelines and a dense network of leading life science institutions foster a vibrant environment for translational research and commercial scale-up. Established biotechnology clusters accelerate partnerships between developers and end users, advancing clinical validation efforts. Europe, the Middle East, and Africa present a mosaic of regulatory frameworks and healthcare infrastructures, where stringent clinical guidelines in Western Europe coexist with emerging markets in the Middle East that leverage strategic investments to enhance research capabilities. This region’s focus on personalized medicine initiatives continues to drive demand for validated miRNA assays. The Asia-Pacific region stands out for rapid capacity expansion supported by government-led genomics programs and private sector investment. Increasing laboratory automation, coupled with favorable reimbursement policies in key markets, propels adoption of high-throughput sequencing platforms. Collectively, these regional insights highlight divergent but complementary growth trajectories, underscoring the importance of adaptive strategies tailored to local regulatory, economic, and infrastructural landscapes.

Competitive Forces Steering miRNA Industry Leaders

Leading companies in the miRNA sequencing and assay sphere are employing diverse strategies to consolidate their market positions and capture emerging opportunities. Established instrument manufacturers are enhancing their platforms with optimized chemistries and intuitive software to support end-to-end workflows, while specialized assay developers are expanding their product lines to include both discovery and diagnostic-grade kits. Market incumbents are forging alliances with bioinformatics providers to deliver integrated data analysis solutions that minimize the barrier between raw sequence data and actionable insights. Simultaneously, contract research organizations are scaling dedicated miRNA services, leveraging economies of scale to offer competitive turnaround times and comprehensive analytical reports. Strategic acquisitions have emerged as a key lever for rapid capability expansion, with several players integrating niche technology firms to bolster their assay portfolios and geographic reach. At the same time, emerging entrants are differentiating through platform-agnostic reagents and open-access analytical pipelines, aiming to capitalize on the growing interoperability of sequencing ecosystems. This competitive tapestry underscores the critical interplay between technological innovation, partnership models, and global market access in defining leadership in the miRNA domain.

Strategic Moves to Seize miRNA Opportunities

Industry leaders can sharpen their competitive edge by aligning strategic priorities across innovation, partnerships, and market engagement. First, investing in modular, scalable platforms that support both high-throughput discovery and targeted diagnostic applications can address diverse end user needs while maximizing return on instrument deployment. Second, cultivating partnerships with regional service providers and diagnostic laboratories will facilitate localized adoption, regulatory approval, and reimbursement pathways. Third, integrating advanced bioinformatics capabilities directly into assay solutions offers a compelling value proposition by reducing time-to-insight and lowering the barrier for clinical translation. Fourth, engaging proactively with regulatory bodies to establish clear guidance for microRNA-based diagnostics will accelerate market entry and foster stakeholder confidence. Finally, developing flexible pricing models and subscription-based services can accommodate budget constraints across academic, clinical, and commercial segments, driving broader uptake of miRNA technologies. By executing these recommendations, organizations can position themselves to capture emerging opportunities and navigate the evolving landscape with agility.

Rigorous Framework Underpinning the Research

The insights presented in this report are grounded in a rigorous research framework that combines primary and secondary data sources, expert consultations, and systematic validation processes. Primary research involved in-depth interviews with key opinion leaders, laboratory directors, and industry executives to capture firsthand perspectives on technology adoption, regulatory hurdles, and unmet needs. Secondary research encompassed a comprehensive review of peer-reviewed publications, regulatory guidelines, company filings, and patent databases to trace technological advancements and competitive dynamics. Quantitative data points were cross-verified through triangulation methods, ensuring consistency across disparate sources. Market segmentation and regional analyses were informed by a detailed examination of procurement patterns, funding initiatives, and clinical trial registries. Throughout the research process, quality assurance measures-such as data integrity checks and subject matter expert reviews-were employed to guarantee the accuracy and relevance of the findings. This robust methodology underpins the strategic recommendations and market insights outlined in the preceding sections.

Synthesizing Insights for miRNA Stakeholders

In synthesizing the multifaceted insights on miRNA sequencing and assay markets, it is clear that technological innovation, supply chain resilience, and strategic partnerships will dictate future trajectories. The interplay between established methods and emerging single-cell approaches, coupled with advancing bioinformatics capabilities, positions miRNA analysis as a pivotal tool in both research and clinical domains. Navigating the challenges posed by new tariffs and regional regulatory variations requires nimble strategic planning and localized engagement. By leveraging detailed segmentation and regional insights, stakeholders can tailor offerings to specific market needs and accelerate the translation of miRNA discoveries into impactful applications. Ultimately, the companies that invest in end-to-end solutions, foster collaborative ecosystems, and prioritize regulatory alignment will lead the charge in unlocking the full potential of miRNA-driven precision medicine.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Expression Assay Kit
      • Microarray Kit
      • Qrt-Pcr Kit
      • Sequencing Kit
    • Sequencing Platform
    • Services
      • Bioinformatics Services
      • Sequencing Services
  • Technology
    • Microarray
    • Next Generation Sequencing
    • Rt-Qpcr
  • Application
    • Clinical Diagnostics
    • Disease Research
    • Drug Discovery
  • End User
    • Academic Institutions
    • Contract Research Organizations
    • Hospitals & Diagnostic Laboratories
    • Pharmaceutical & Biotech
  • Workflow
    • Consumables
      • Kits & Reagents
      • Labware
    • Services
      • Data Analysis Services
      • Sequencing Services
  • Sample Type
    • Blood
    • Serum/Plasma
    • Tissue
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Takara Bio Inc.
  • New England Biolabs, Inc.
  • NanoString Technologies, Inc.
  • PerkinElmer, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. miRNA Sequencing & Assay Market, by Product Type
8.1. Introduction
8.2. Expression Assay Kit
8.2.1. Microarray Kit
8.2.2. Qrt-Pcr Kit
8.2.3. Sequencing Kit
8.3. Sequencing Platform
8.4. Services
8.4.1. Bioinformatics Services
8.4.2. Sequencing Services
9. miRNA Sequencing & Assay Market, by Technology
9.1. Introduction
9.2. Microarray
9.3. Next Generation Sequencing
9.4. Rt-Qpcr
10. miRNA Sequencing & Assay Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.3. Disease Research
10.4. Drug Discovery
11. miRNA Sequencing & Assay Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Contract Research Organizations
11.4. Hospitals & Diagnostic Laboratories
11.5. Pharmaceutical & Biotech
12. miRNA Sequencing & Assay Market, by Workflow
12.1. Introduction
12.2. Consumables
12.2.1. Kits & Reagents
12.2.2. Labware
12.3. Services
12.3.1. Data Analysis Services
12.3.2. Sequencing Services
13. miRNA Sequencing & Assay Market, by Sample Type
13.1. Introduction
13.2. Blood
13.3. Serum/Plasma
13.4. Tissue
14. Americas miRNA Sequencing & Assay Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa miRNA Sequencing & Assay Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific miRNA Sequencing & Assay Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Illumina, Inc.
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. QIAGEN N.V.
17.3.4. Agilent Technologies, Inc.
17.3.5. F. Hoffmann-La Roche Ltd
17.3.6. Bio-Rad Laboratories, Inc.
17.3.7. Takara Bio Inc.
17.3.8. New England Biolabs, Inc.
17.3.9. NanoString Technologies, Inc.
17.3.10. PerkinElmer, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MIRNA SEQUENCING & ASSAY MARKET MULTI-CURRENCY
FIGURE 2. MIRNA SEQUENCING & ASSAY MARKET MULTI-LANGUAGE
FIGURE 3. MIRNA SEQUENCING & ASSAY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MIRNA SEQUENCING & ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY MICROARRAY KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY QRT-PCR KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY RT-QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY DISEASE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY LABWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERUM/PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 67. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 72. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 77. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 82. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 83. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 84. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 128. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 133. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 136. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 138. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 139. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 143. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 144. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 145. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 158. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 163. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 164. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 165. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 168. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 173. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 174. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 175. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 208. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 213. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 214. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 228. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 229. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 233. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 234. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 235. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 238. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 239. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 243. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 244. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 268. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 273. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 274. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 275. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 276. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 278. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 279. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 283. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 284. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 285. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 296. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 298. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 299. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 303. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 304. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 305. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 306. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 308. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 309. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 313. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 314. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 315. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 326. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY EXPRESSION ASSAY KIT, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABL

Companies Mentioned

The companies profiled in this miRNA Sequencing & Assay market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Takara Bio Inc.
  • New England Biolabs, Inc.
  • NanoString Technologies, Inc.
  • PerkinElmer, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 435.69 Million
Forecasted Market Value ( USD ) by 2030 $ 843.15 Million
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
miRNA Sequencing and Assays - Global Strategic Business Report - Product Image

miRNA Sequencing and Assays - Global Strategic Business Report

  • Report
  • 465 Pages
  • Global
From
MicroRNA Market Report 2025 - Product Image

MicroRNA Market Report 2025

  • Report
  • 200 Pages
  • Global
From
MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
microRNA (miRNA) - Global Strategic Business Report - Product Image

microRNA (miRNA) - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.